A life sciences startup led by a former Spark Therapeutics researcher is raising funding to move a rheumatoid arthritis therapy toward clinical trials.

A breakthrough in CAR-T therapy may allow cancer treatment with a single injection, cutting costs and making care more available.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients who received only an immune-based treatment to help their own immune ...

Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and ...

Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the ...

Scientists from Belgian biotech company etherna, who are working on inverse RNA vaccines for multiple sclerosis and other autoimmune diseases. For decades, the only option available to patients ...

Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.

Immune therapy is generally safer than chemotherapy, allowing more patients with melanoma and other conditions like heart or lung issues receive treatment. Immune therapy is generally better tolerated ...

Chimeric antigen receptor (CAR) T-cell therapy has been an exciting area of development for autoimmune disease treatment. Previous reports had not mentioned any particular constellation of adverse ...

It’s shocking to see the news that autoimmune conditions are skyrocketing. And 80 percent of cases are in women, according to research in Frontiers in Endocrinology. When the body attacks itself, as ...